At Magwise Clinic, we also offer non-pharmacological migraine treatment based on neurostimulation, developed according to the latest clinical evidence and protocols inspired by the experience of MagVenture.
This method combines:
- Transcranial Magnetic Stimulation (TMS)
- Peripheral Magnetic Nerve Stimulation (mPNS)
This approach targets both central and peripheral mechanisms responsible for migraine development.
In migraine pain, TMS is a non-invasive brain stimulation technique primarily aimed at the motor cortex, using an FDA-approved protocol for chronic pain treatment. By modulating neuronal activity in pathways responsible for transmitting pain signals, TMS helps reduce the frequency and severity of migraine attacks.
Additionally, mPNS therapy is applied, based on gentle peripheral magnetic stimulation that produces therapeutic effects by mobilising areas around the shoulders, neck, and cervical spine. This helps to relax neuro-muscular tension, which plays a role in migraine development.
Clinical studies, including the work by Leahu et al. (2021), have shown that combining TMS and mPNS can significantly extend migraine-free periods and improve the overall quality of life for patients suffering from frequent migraines.
At Magwise Clinic, the neurostimulation programme is personalised, evidence-based, and designed to provide a safe, non-invasive, and drug-free migraine prophylaxis for those seeking an effective alternative or complement to pharmacotherapy.
Peripheral magnetic nerve stimulation is a comfortable method for migraine patients, which can reduce local muscular pain or tension. Symptom relief was achieved through stimulation of the myofascial trigger points of the trapezius muscles, which are considered part of the trigeminocervical complex.
- Renner, T., et al. (2019), Frontiers in Neurology